Sagewind Capital

The firm is led by its senior investment team under founder Steve Lefkowitz. The team includes Raj Kanodia, Gerry Dorros, Joshua Coonin, David Dansky, Jeremy Peterson, Rhea Oberoi, Will Schmersal, and Austin Reilly. Sagewind does not publicly designate CEO or CIO titles; the website lists all investment professionals under a single 'Investment' category (per firm website).

Sagewind leans on a senior team whose Government Technology experience dates to 1993, combined with an advisory council of industry and operating executives who provide sector-specific networks. The firm’s website notes that this council collaborates closely with management and participates in diligence, creating a proprietary sourcing channel through deep, long-tenured relationships rather than auction processes (per firm website).

Sagewind is a direct investor deploying equity into individual middle-market companies. It structures deals as buyouts, growth equity, and PIPEs, with no mention of fund-of-fund commitments. The strategy is built around control or significant minority positions where the team can actively support operational and strategic growth (per firm website).

The firm writes equity checks from $10 million to $150 million into companies generating between $5 million and $40 million in annual EBITDA. It invests across buyout, growth equity, and PIPE transactions, and explicitly targets a 5-to-10-year holding period, longer than the standard private equity timeline (per firm website).

Sagewind focuses exclusively on Defense Technology and Government Technology, the only two verticals listed. The firm does not invest in consumer, healthcare, traditional industrials, or other sectors outside this mandate. The concentrated approach is reinforced by an investment team whose sector experience dates to 1993 (per firm website).

Sagewind advertises a patient capital approach with a 5-to-10-year hold, roughly double the typical PE horizon. This is designed to give founder-led management teams more time to execute on strategic plans, including organic R&D and disciplined acquisition-led growth, without the pressure to exit for a fund-lifecycle deadline (per firm website).